ZIMMER BIOMET, INC.

Lobbying for ZIMMER BIOMET, INC.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $170,000.00 expenses · posted Oct 17, 2025

Lobbying activity 5

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues; ACA Tax Credit

Health Issues

Assorted issues related to the FDA

Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.